Anti-tenascin monoclonal antibody BC-4-I-131

N/A

Report date: 2022/03/23 17:09:29

Base Information

Drug NameAnti-tenascin monoclonal antibody BC-4-I-131
Drug Alias NameBC-4-I-131
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionImmunostimulantsIonising radiation emittersanti-Tenascin
TargetsTenascin
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A